Glasmacinal

N/A

Report date: 2026/03/04 20:01:44
NME

Base Information

Drug NameGlasmacinal
Drug Alias NameBarriolideEP-395
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpithelial cells stimulants
TargetsUpdating
Therapy Area/IndicationsPulmonary Disease, Chronic ObstructivePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwedenGermanyUnited Kingdom +[4
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesEpiEndo Pharmaceuticals ehf.
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPulmonary Disease, Chronic ObstructivePrecursor Cell Lymphoblastic Leukemia-Lymphoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A